Latest California Healthline Stories
KHN’s ‘What the Health?’: Life After ‘Roe’ Is … Confusing
A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
Igual que con covid, atraso en pruebas y vacunas para la viruela del simio
Los casos de la viruela del simio siguen aumentando, pero la respuesta sanitaria es lenta: escasean las pruebas y las dosis de la vacuna que puede prevenir la infección.
Buy and Bust: When Private Equity Comes for Rural Hospitals
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.
KHN’s ‘What the Health?’: Washington’s Slow Churn
Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts. Click here for a transcript of the episode. In the wake of three high-profile mass shootings in less than a month, lawmakers on Capitol Hill have renewed […]
Why So Slow? Legislators Take on Insurers’ Delays in Approving Prescribed Treatments
Insurers say prior authorization requirements are intended to reduce wasteful and inappropriate health care spending. But they can baffle patients waiting for approval. And doctors say that insurers have yet to follow through on commitments to improve the process.
Is Paxlovid, the Covid Pill, Reaching Those Who Most Need It? The Government Won’t Say
Many public health workers are unable to see how many doses of Pfizer’s antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.
National Addiction Treatment Locator Has Outdated Data and Other Critical Flaws
Three years after a government site launched to connect Americans to treatment, finding addiction care is still a struggle.
At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills
Prosecutors say opioid-seeking patients drove hours to get their prescriptions filled in Celina, Tennessee, where pharmacies ignored signs of substance misuse and paid cash — or “monkey bucks” — to keep customers coming back.
It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.